Bank of Montreal’s Gossamer Bio GOSS Stock Holding History

Bank of Montreal’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-83	Closed	-$9.9K	–	3980
2023 Q2	$9.9K	Buy	+83	New	+$8.27K	﹤0.01%	3802

Other funds holding GOSS

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Bank of Montreal's GOSS Position: Q3 2023 in Review

Bank of Montreal sold out of Gossamer Bio (GOSS) in Q3 2023, closing a stake of 100 shares — an estimated $12K sold.

Bank of Montreal first reported a position in GOSS in Q1 2019 and held it in 11 quarters. The position peaked at $99K in Q4 2020. 94 funds tracked by Wall St. Rank hold GOSS as of Q3 2023.

Bank of Montreal reported no remaining Gossamer Bio position as of Q3 2023 after selling out during the quarter.
Bank of Montreal sold 100 Gossamer Bio shares in Q3 2023, an estimated $12K.
Bank of Montreal first reported a position in Gossamer Bio in Q1 2019 and held it in 11 quarters.
Bank of Montreal's Gossamer Bio position peaked at $99K in Q4 2020.
94 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2023.

Based on Bank of Montreal's 13F filing for Q3 2023, filed 1 Nov 2023.